Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 24, 2017 – Shionogi and Purdue Pharma announced the FDA approval of Symproic (naldemedine) for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
Return to publications